Monoclonal Antibodies Market to Grow at 11.01% CAGR, Reaching USD 791.28 Billion by 2035 – SNS Insider
The global monoclonal antibodies market is projected to grow from USD 280.15 billion in 2025 to USD 791.28 billion by 2035, driven by increasing demand for targeted therapies in oncology, autoimmune disorders, and chronic diseases. North America leads with 41% market share, while Asia-Pacific shows the fastest growth at 12.32% CAGR. Key innovations include bispecific antibodies and antibody-drug conjugates, with humanized antibodies emerging as the fastest-growing segment.